Abstract--Human
INTRODUCTION
Rare variants of nonhepatic cells that express high levels of AS mRNA, equivalent to tllO~;~ ill "'--'-" ..... can be :-^'-'^'~ ~" .... '~ tion in the presence of the arginine analog, canavanine (1) . The human squamous cell carcinoma line, RPMI 2650, gives rise to variants at a frequency of 10 6-10-7 when using micromolar concentrations of canavanine. Interestingly, these canavanine-resistant cell variants stably express 200-fold increased levels of AS mRNA as compared to parental RPMI 2650 cells without amplification of AS genomic sequences (1) . Previous studies using AS promoter-gone fusions showed that the human A~S promoter was net more transcriptionally active in canavanine-resistant cell variants when added exogenously (2, 3) . These results raised the possibility that the regulatory elements that are necessary for the induction of AS mRNA in canavanine-resistant cells might be intragenic. This possibility is the subject of the present report.
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MATERIALS AND METHODS

Construction of RSV-AS Expression
Plasmids. RSV-AS contains sequences from the AS cDNA, pAS419 (4) , from the AvaI site at base 1 to the PvulI site at base 1510 (5) . These sequences were cloned between the HindlII and BgllI sites of RSV/3-globin (6) , after removal of the/3-globin sequences. RSV-AS A HindlII was constructed by digesting RSV-AS with HindlII, filling in the recessed ends with the Klenow subunit of DNA polymerase, followed by ligation with T4 DNA ligase. RSV-AS A HindlII was verified as being unable to produce a functional AS gene product by transfection of Chinese hamster RJK88 cells followed by selection in medium lacking arginine but containing citrulline (DMEM-a+c) (2) . RJK88 cells lack endogenous AS activity and will die in DMEM-a+c unless complemented with an exogenous and functional AS gene. RSV-AS A HindlI1 failed to yield colonies in this assay whereas the parental plasmid, RSV-AS, produced hundreds of colonies. RSV-AS A HindlII-ter was constructed as follows. The plasmid pAS412/pUC-8, which contains the 1.3-kb PstI cDNA insert of pAS412 (5) cloned into the PstI site of pUC-8, was digested with BamHI and HindlII. A 250-bp Bam HI-HindlII fragment, which contains the first 232 bp of the AS cDNA, was isolated, and the ends were made blunt with the Klenow subunit of DNA polymerase. This blunted fragment was then cloned between the HindlII and BgllI sites of RSV/3-globin after removal of the ~-globin sequences and blunting of the HindlII and BgllI ends with the Klenow subunit of DNA polymerase.
Cell Culture and Plasmid DNA Transfections. The maintenance of cell lines in culture, selection of canavanine-resistant cell variants and plasmid DNA transfections were performed as previously described (2, 7) . In a typical experiment, 10-20 canavanine-resistant colonies were obtained in three to four weeks from 1-2 • 10 7 cells. The cells were then pooled and grown en masse for preparation of RNA. Quantification of the endogenous AS RNA and RSV-AS RNA was performed within two to four weeks following pooling of canavanine-resistant colonies to minimize the outgrowth of nonrepresentative clones. S1 Nuclease Assays. Total cellular RNA was isolated using the guanidinium isothiocyanate-CsC1 density gradient method (8) . DNA probes for S1 nuclease assays were prepared by 5'-end labeling the DNA using [32P]3,-ATP and polynucleotide kinase (8) . S1 nuclease assays were performed using total cellular RNA as previously described (2, 7) . Reaction products were applied to 8% polyacrylamide sequencing gels and protected fragments were visualized by autoradiography.
RESULTS
To test the possibility that AS exon sequences were involved in the 200-fold induction of AS mRNA in canavanine-resistant cells, we constructed the expression plasmid RSV-AS (Fig. 1) . RSV-AS contains a nearly full-length AS cDNA positioned downstream of the Rous sarcoma virus (RSV) promoter. This cDNA lacks the first 27 bases of exon 1 and the last 37 bases of the terminal exon, which includes polyadenylation signal sequences. Splicing and polyadenylation functions are provided by the vector. Cloned RPMI 2650 cell lines stably expressing RSV-AS were obtained by cotransfection of RSV-AS plasmid DNA with the dominant selectable marker gene, RSVneo (6) . Cell lines were screened for expression of RSV-AS mRNA by S1 nuclease assays (data not shown), and canavanine-resistant variants for each expressing cell line were obtained by selection in media containing 3 #M canavanine (2) . Expression of the endogenous AS gene and RSV-AS cDNA minigene in parental cells and in pooled canavanine-resistant cell lines was examined using quantitative S1 nuclease assays (Fig. 2) . The endogenous AS RNA is alternatively spliced including or deleting exon 2 (4) and thus yields two protected fragments with the probe used in these assays. In cell line R30B4, which expressed relatively low levels of RSV-AS mRNA, expression of the endogenous A S gene increased by two orders of magnitude upon conversion of cells to canavanine-resistance, as expected (Fig. 2,  lanes c and d) . Surprisingly, however, we observed a concomitant 10-to 15-fold decrease in RSV-AS expression upon induction of the endogenous A S gene in canavanine-resistance cells 9 The observed down-modulation was observed in two other independent cell lines that also expressed low levels of RSV-AS (data not shown) 9 These findings lntllcateu Lnat expression of all /~ t;L~• minigene was regulated in a reciprocal fashion to the endogenous A S gene and raised the possibility that the two A S genes (mRNAs) were competing for a common regulatory mechanism in canavanine-resistant cells 9 In contrast, in cell line R30B2, which expressed high levels of RSV-AS mRNA, the endogenous AS mRNA was only minimally induced Fig. 2 . Quantification of endogenous AS and AS cDNA minigene RNA using S1 nuclease analysis. Fifty micrograms of total cellular RNA were used in all assays. "l~he probe was linearized RSV-AS 5' end-labeled at the HindlII site in AS cDNA sequences. The endogenous AS mRNA lacking exon 2 gives a wide region of protection when using this probe and is probably the result of "nibbling" by S1 nuclease. The identities of the protected fragments are indicated. H, HindlII; E, EcoRI. The numbers on the left indicate the migration of DNA markers (MspI-digested pUC-9).
upon conversion of cells to canavanine-resistance, while RSV-AS expression was essentially unchanged (Fig. 2, lanes a and b) . It is l i k e l y LtlI:t_L LII~ UIILIU~IIUU:~ /~*..~ l l l I~l~l /~ ~vV~S induced only slightly in cell line R30B2 since these cells were partially resistant to canavanine, probably due to the high levels of RSV-AS mRNA.
Other cell lines (N > 10) that acquired canavanine-resistance without inducing the endogenous A S gene did not exhibit downmodulation of RSV-AS expression (unpub-lished data). Since these cell lines contain a full-length AS c D N A minigene that does not produce a functional AS enzyme (see below), they have acquired resistance to canavanine through an alternative mechanism that does not involve high A S expression. Thus, it is clear that down-modulation of RSV-AS expression is not due to a culture artifact and requires concomitant induction of the endogenous A S gene.
In order to be certain that the observed down-modulation of RSV-AS was not the result of selection pressures against recombinant AS enzyme activity, an additional cell line, R31A1, was constructed using an RSV-AS minigene containing a frameshift mutation near the amino terminal end of the AS coding region (at amino acid position 53, see open arrowhead Fig. 1 ). Pooled canavanineresistant variants of this cell line also showed a 10-to 15-fold decrease in RSV-AS expression concomitant with induction of the endogenous A S gene (Fig. 3, lanes a and c) . To rule out the possibility that this paradoxical response was due to a nonspecific down-modulation of cellular m R N A s in canavanine-resistant cells, we examined the expression of another cellular gene coding for triose phosphate isomerase (TPI) (9) . The results show that expression of the TPI gene was unaffected upon conversion of cells to canavanine-resistance (Fig. 3, lanes  a and c) .
It was possible that the observed downmodulation of RSV-AS expression was due to a nonspecific effect on the viral promoter or polyadenylation sequences contained in these minigenes. Therefore, we examined the expression of another transfected gene, RSVneo, which also utilizes the same RSV promoter and SV40 splicing and polyadenylation sequences contained in RSV-AS. The results show that unlike RSV-AS, expression of R S Vneo was unaltered in canavanine-resistant variants of cell line R31AI (Fig. 4A) . To confirm that AS c D N A sequences were necessary for the observed down-modulation, a derivative of RSV-AS, RSV-AS A HindlII- Fig. 3 . S1 nuclease analysis showing down-modulation of RSV-AS A HindlII, a minigene containing a frameshift mutation. Lanes a and c, 50 #g of total cellular RNA; lane b, 10 #g of total cellular RNA. The probe used to detect the AS RNAs is the same as that described in the legend of Fig. 2 . The probe used to detect triose phosphate isomerase (TPI) mRNA was a 936-bp EcoRI fragment of the human cDNA (9) 5' end-labeled at the EcoRI sites.
ter, which lacks a substantial portion of the AS c D N A was constructed and tested. This minigene contains only the 5' terminal 232 bases of the AS cDNA and lacks approximately 1300 bases of cDNA 3' to the HindlII site (see Fig. 1 ). As before, this derivative was stably introduced into R P M I 2650 cells followed by selection of canavanine-resistant cell variants. Quantification of R N A in parental cells and canavanine-resistant cell variants revealed that RSV-AS/x HindllI-ter m R N A was expressed equally in both cell types (Fig.  4B) . Thus, the paradoxical down-modulation of RSV-AS expression in canavanine-resis- anine-resistant cells. Indeed, previous studies have shown that the human AS gene is subject to two independently acting regulatory mechanisms in RPMI 2650 cells (2, 3) , one of which results in repression of AS gene expression while the other induces AS mRNA levels 200-fold. However, expression of RSV-AS is unaffected by the concentration of arginine in the medium (unpublished data); thus, the observed down-modulation of RSV-AS expression is not the metabolite-mediated repression previously described for the natural AS gene (1). This observation is consistent with the findings that AS promoter-fusion genes are subject to repression by arginine in RPMI 2650 cells (2, 3) .
Our data are consistent with a model that proposes that the endogenous AS gene is controlled by a specific and limiting, positively-acting, trans-acting mechanism (factor) in canavanine-resistant cells and that exogenous AS cDNA sequences can compete for this mechanism. We have provided three lines of evidence supporting the conclusion that the observed down-modulation of RSV-AS is specific for AS gene sequences: (1) expression of another transfected gene, RSVneo, which differs from RSV-AS only by substitution of neo sequences for AS sequences, does not exhibit the down-modulation; (2) expression of another cellular gene, TPI, is not subject to this regulation; and (3) deleting a portion of the AS cDNA from RSV-AS eliminates the down-modulation. The observation that the endogenous AS gene and transfected cDNA minigenes are regulated in a reciprocal fashion suggests that the two AS genes (mRNAs) are competing for a common mechanism (factor). Thus, it follows that this mechanism (factor) must be limiting, otherwise the apparent competition would not have been observed. If this competition model is correct, the mechanism (factor) must be positive-acting since RSV-AS expression decreases concomitantly with increased expression of the endogenous AS gene. This conclusion is based on the expectation that titration of a negative-acting mechanism (factor), by increasing expression of the endogenous AS gene, would have resulted in derepression of RSV-AS expression. The mechanism is clearly trans-acting since expression of exogenously added AS cDNA minigenes is affected. Finally, the mechanism appears to be operating in the nucleus since canavanine-resistant variants of R30B2 cells also contain reduced amounts of RSV-AS RNA in the poly(A)-RNA fraction (unpublished observations).
Is this model consistent with all known facts regarding regulation of the endogenous AS gene in canavanine-resistant cells? Other studies from this laboratory have shown that high expression of AS mRNA is mediated through a positive-acting mechanism operating in the nucleus of canavanine-resistant cells (7) . Furthermore, studies using canavanineresistant lymphoblasts have indicated that this mechanism is trans-acting (2) . Thus, our model, which invokes the existence of a single, positively-acting, trans-acting nuclear mechanism (factor), is consistent with all known facts regarding high AS expression in canavanine-resistant cells. Our model requires that this mechanism (factor) be limiting, suggesting that its efficiency, but not its concentration, increases in canavanine-resistant cells. Therefore, the model invokes a change in the affinity of this mechanism (factor) for AS gene (mRNA) sequences and that the affinity for endogenous AS gene (mRNA) sequences is greater than the affinity for RSV-AS gene (mRNA) sequences in canavanine-resistant cells. This mechanism (factor) could have different affinities for the endogenous AS gene (mRNA) and RSV-AS gene (mRNA) if it interacts with AS intron sequences that are absent from RSV-AS. Alternatively, it could recognize a unique secondary structure in the endogenous AS RNA. However, since minigenes containing only AS cDNA sequences are subject to the down-modulation, this mechanism (factor) must interact with AS exon sequences. It is important to note that this model makes no assumption whether the down-modulation involves AS gene or RNA sequences and thus is consistent with a mechanism that acts either at the transcriptional or posttranscriptional level. Support for this model will require mapping the sequences involved in this regulation and construction of RSV-AS derivatives containing AS intron sequences. Our task is made more difficult by the large size of the human AS gene (63 kb) and the large number of introns (4) . Nevertheless, it is clear that the human AS gene is subject to a novel regulatory mechanism that warrants further investigation. 
